Civil law injunctions and damages for infringement are national security hot spots 4% (10 votes) ACTA negotiators don’t want people asking informed questions about the substance of the agreement 69% (191 votes) No one in the Administration cares enough about… Continue Reading
On October 14, 2009, KEI submitted a FOIA request to the USTR, which is available here, asking for the following records:
KEI requests all records at USTR on the topic of the policy and practice of USTR regard the transparency of trade negotiations, including but not limited to the Anti-Counterfeiting Trade Agreement (ACTA).
KEI is one of several public health groups working with Sean Flynn on filing comments in the current U.S.T.R. request for comments on the Special 301 process (Federal Register Notice USTR-2010-0003-0129). In addition, KEI filed these comments:
KEI comments on Special 301
18 February 2010
KEI provides the following comments regarding the 2010 Special 301 Review, including but not limited to the Identification of Countries Under Section 182 of the Trade Act of 1974.
Our comments include the following points:
Original at: https://tacd.org/wp-content/uploads/2013/09/TACD-IP-07-09-IP-Aspects-of-Pandemics.pdf Resolution on Intellectual Property Aspects of Pandemics DOC No. IP 07-09 DATE ISSUED: May 2009 Introduction In recent years there have been several cases of possible new pandemics of infectious diseases. This includes recently concerns about SARS,… Continue Reading
The following report was prepared by KEI, and reviewed by Daniel Sepulveda of USTR:
By resolution WHA 59.24, the WHO’s Intergovernmental Working Group on Public Health, Innovation, and Intellectual Property (IGWG) has the goal of producing a Global Strategy and Plan of Action that will implement the CIPIH report recommendations and “secure an enhanced and sustainable basis for needs-driven, essential health research and development relevant to diseases that disproportionately affect developing countries, proposing cle Continue Reading
On May 30, KEI hosted a brown bag lunch discussion on guidelines for the new U.S. trade policy recently released by the Congressional Ways and Means Committee and the Bush Administration. The event began with brief statements by panelists Fabiana… Continue Reading
Monday, 30 April 2007 “The sanctioning of countries for using legitimate and important flexibilities in the TRIPS agreement brings shame to all U.S. citizens who are increasingly seen in Thailand and elsewhere as bullies and hypocrites.” The following is the… Continue Reading
Here is a link to the text of the WHO EB’s draft resolution on the resport of the WHO Commission on Intellectual Property, Innovation and Public Health (CIPIH). http://www.cptech.org/ip/health/who/WHOcipih280406.html from the mini EB meeting on April 28. The US government… Continue Reading
March 2006
CPTech Response to 2006 PhRMA “Special 301” Submission for Chile
The “Special 301” Report is a report that the office of the U.S. Trade Representative (USTR) submits annually to the House Ways and Means Committee and the Senate Finance Committee on the adequacy and effectiveness of intellectual property rights protection around the world. The report identifies those countries that the USTR consider “deny adequate and effective protection for IPR or deny fair and equitable market access for U.S. persons that rely on intellectual property protection”.